300 (Label 300mg)
Oxcarbazepine Tablet, Film Coated
Product Images NDC 87063-208
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 87063-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Oxcarbazepinfig1 (Oxcarbazepinfig1)
This is a description of an evaluation at day 2 at 8 am comparing the exit rate between a Treatment Group (smmmsm Oxcarbazepine) and Placebo. A log-rank test was conducted, resulting in a p-value of 0.0001. This information can be useful for analyzing the effectiveness of the treatment on day 2 in determining the time spent on a trial. Further details about the trial and its outcomes are not available in the provided text.*
Oxcarbazepinfig2 (Oxcarbazepinfig2)
This text provides information on seizure rate analysis using a log-rank test with a p-value of 0.046. It also includes a graph showing the days from the 1st dose to the 1st seizure for the treatment group using Oxcarbazepine. The data includes time points from 0 to 140 days.*
Oxcarbazepinfig3 (Oxcarbazepinfig3)
Oxcarbazepinfig4 (Oxcarbazepinfig4)
Oxcarbazepinstructure (Oxcarbazepinstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
